Borregaard ASA (BRG) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Borregaard ASA (BRG) has a cash flow conversion efficiency ratio of 0.071x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Nkr419.00 Million ≈ $44.09 Million USD) by net assets (Nkr5.88 Billion ≈ $618.53 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Borregaard ASA (BRG) balance sheet quality index to measure how much of total assets are equity-financed.
Borregaard ASA - Cash Flow Conversion Efficiency Trend (2009–2025)
This chart illustrates how Borregaard ASA's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check BRG cash flow quality index to evaluate the quality of earnings relative to operating cash generation.
Borregaard ASA Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Borregaard ASA ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
China TransInfo Technology Co Ltd
SHE:002373
|
0.022x |
|
U-Ming Marine Transport Corp
TW:2606
|
0.063x |
|
Yusys Technologies Co Ltd Class A
SHE:300674
|
0.008x |
|
Ivanhoe Electric Inc.
NYSE MKT:IE
|
-0.094x |
|
Jiangsu Cnano Technology Co Ltd
SHG:688116
|
0.024x |
|
Wuhan Tianyuan Environmental Protection Co.LTD
SHE:301127
|
N/A |
|
Guangdong Mingyang Electric Co. Ltd. A
SHE:301291
|
N/A |
|
Welspun Living Limited
NSE:WELSPUNLIV
|
N/A |
Annual Cash Flow Conversion Efficiency for Borregaard ASA (2009–2025)
The table below shows the annual cash flow conversion efficiency of Borregaard ASA from 2009 to 2025. For the full company profile with market capitalisation and key ratios, see Borregaard ASA market cap and net worth.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | Nkr5.88 Billion ≈ $618.53 Million |
Nkr1.36 Billion ≈ $142.69 Million |
0.231x | +9.95% |
| 2024-12-31 | Nkr5.09 Billion ≈ $535.61 Million |
Nkr1.07 Billion ≈ $112.38 Million |
0.210x | -34.30% |
| 2023-12-31 | Nkr4.89 Billion ≈ $514.99 Million |
Nkr1.56 Billion ≈ $164.47 Million |
0.319x | +93.14% |
| 2022-12-31 | Nkr4.45 Billion ≈ $467.74 Million |
Nkr735.00 Million ≈ $77.34 Million |
0.165x | -50.24% |
| 2021-12-31 | Nkr4.31 Billion ≈ $453.12 Million |
Nkr1.43 Billion ≈ $150.58 Million |
0.332x | +41.71% |
| 2020-12-31 | Nkr3.78 Billion ≈ $397.55 Million |
Nkr886.00 Million ≈ $93.23 Million |
0.235x | +16.55% |
| 2019-12-31 | Nkr3.46 Billion ≈ $364.51 Million |
Nkr697.00 Million ≈ $73.34 Million |
0.201x | +19.75% |
| 2018-12-31 | Nkr3.32 Billion ≈ $349.46 Million |
Nkr558.00 Million ≈ $58.72 Million |
0.168x | -35.46% |
| 2017-12-31 | Nkr3.00 Billion ≈ $315.27 Million |
Nkr780.00 Million ≈ $82.08 Million |
0.260x | -34.66% |
| 2016-12-31 | Nkr2.71 Billion ≈ $285.49 Million |
Nkr1.08 Billion ≈ $113.75 Million |
0.398x | +45.86% |
| 2015-12-31 | Nkr2.06 Billion ≈ $216.88 Million |
Nkr563.00 Million ≈ $59.24 Million |
0.273x | -11.27% |
| 2014-12-31 | Nkr1.95 Billion ≈ $205.09 Million |
Nkr600.00 Million ≈ $63.14 Million |
0.308x | +5.81% |
| 2013-12-31 | Nkr1.86 Billion ≈ $195.30 Million |
Nkr540.00 Million ≈ $56.82 Million |
0.291x | -8.28% |
| 2012-12-31 | Nkr1.74 Billion ≈ $182.78 Million |
Nkr551.00 Million ≈ $57.98 Million |
0.317x | -33.54% |
| 2011-12-31 | Nkr1.12 Billion ≈ $118.17 Million |
Nkr536.00 Million ≈ $56.40 Million |
0.477x | +7.07% |
| 2010-12-31 | Nkr1.01 Billion ≈ $106.70 Million |
Nkr452.00 Million ≈ $47.56 Million |
0.446x | +19.84% |
| 2009-12-31 | Nkr1.35 Billion ≈ $142.59 Million |
Nkr504.00 Million ≈ $53.04 Million |
0.372x | -- |
About Borregaard ASA
Borregaard ASA engages in the development, production, and marketing of specialized biochemicals and biomaterials in Norway, rest of Europe, Asia, the United States, and internationally. It operates in three segments: BioSolutions, BioMaterials, and Fine Chemicals. The company develops, produces, and sells biopolymers and biovanillin for agrochemicals, batteries, industrial binders, and construct… Read more